<p>Zilbrysq is a medicine used to treat generalised myasthenia gravis (a disease that leads to muscle weakness and tiredness) in adults whose immune system produces antibodies against a protein called the acetylcholine receptor. It is given together with other medicines used for treating myasthenia gravis.</p><p>Zilbrysq contains the active substance zilucoplan.</p>
Therapeutic Indication
<div class="subsection mt-3-5"> <h3>Therapeutic indication</h3><p>Zilbrysq is indicated as an add-on to standard therapy for the treatment of generalised myasthenia gravis (gMG) in adult patients who are anti-acetylcholine receptor (AChR) antibody positive.</p> </div>
Therapeutic Area (MeSH)
ATC Code
L04AJ06
ATC Item
N/A
Pharmacotherapeutic Group
Immunosuppressants
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| zilucoplan | N/A | zilucoplan |
EMA Name
Zilbrysq
Medicine Name
Zilbrysq
Aliases
N/ANo risk management plan link.
